MUC1-C DEPENDENCY IN DRUG RESISTANT HR+/HER2- BREAST CANCER IDENTIFIES A NEW TARGET FOR TREATMENT WITH AN ANTIBODY-DRUG CONJUGATE

NIAID Data Ecosystem2026-05-02 收录

癌症靶向治疗

肿瘤耐药机制

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272989 数据链接链接失效反馈

官方服务：

资源简介：

MUC1-C is a common effector of treatment resistant HR+/HER2- BC cells and is a potential target for their treatment RNA Seq in HR+/HER2- Cell lines with doxicicline inducible MUC1-C shRNA silencing

创建时间：

2025-05-09

MUC1-C DEPENDENCY IN DRUG RESISTANT HR+/HER2- BREAST CANCER IDENTIFIES A NEW TARGET FOR TREATMENT WITH AN ANTIBODY-DRUG CONJUGATE

资源简介：

相关数据集